Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,745 | -30,427 | -903 | 61,022 | -209,248 |
| Depreciation Amortization | 1,561 | 1,362 | 889 | 437 | 1,449 |
| Accounts receivable | -31,648 | -19,330 | -11,866 | -6,118 | -14,765 |
| Accounts payable and accrued liabilities | 12,432 | 3,128 | 15,898 | -3,450 | 8,678 |
| Other Working Capital | -60,530 | -39,222 | -26,802 | -21,803 | 13,675 |
| Other Operating Activity | 106,276 | 95,787 | 69,407 | 23,740 | 64,724 |
| Operating Cash Flow | $-23,654 | $11,298 | $46,623 | $53,828 | $-135,487 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -317 | -317 | -150 | -73 | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 42,500 |
| Investing Cash Flow | $-317 | $-317 | $-150 | $-73 | $42,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 245,102 | N/A | N/A | N/A | N/A |
| Debt Repayment | -210,088 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 106,022 | 106,040 | 105,509 | 96,438 | 65,966 |
| Other Financing Activity | -54,552 | -54,552 | -44,926 | -5,832 | -15,506 |
| Financing Cash Flow | $86,484 | $51,488 | $60,583 | $90,606 | $50,460 |
| Beginning Cash Position | 82,248 | 82,248 | 82,248 | 82,248 | 124,775 |
| End Cash Position | 144,761 | 144,717 | 189,304 | 226,609 | 82,248 |
| Net Cash Flow | $62,513 | $62,469 | $107,056 | $144,361 | $-42,527 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,654 | 11,298 | 46,623 | 53,828 | -135,487 |
| Capital Expenditure | -317 | -317 | -150 | -73 | N/A |
| Free Cash Flow | -23,971 | 10,981 | 46,473 | 53,755 | -135,487 |